We are the TRANSFAC company, Welcome to geneXplain, home of TRANSFAC®, the essential database for transcription factors. Since 2010 in Germany, we led in bioinformatics, providing top databases & software tools to scientific community. TRANSFAC®: With 35 years of history, TRANSFAC® offers info on TFs, binding sites, regulated genes & interaction partners. Our PWM library is globally renowned for identifying new transcription factor binding sites (TFBSs). HumanPSD™+TRANSPATH®: Complement TRANSFAC® by identifying master regulators in signal transduction networks, providing insights into pathways, gene-disease associations, disease similarity maps & protein-drug interactions. MATCH™ Suite: Automatic pipeline for identifying TFBSs in promoters & enhancers across tissues & processes. geneXplain™ Platform & Genome Enhancer: Software that supports the drug development pipeline, from analyzing high-throughput omics data to identifying master regulatory molecules & potential drug targets.
Looking for a particular geneXplain employee's phone or email?
The geneXplain annual revenue was $1 million in 2026.
Alexander Kel is the CEO of geneXplain.
13 people are employed at geneXplain.
geneXplain is based in Wolfenbüttel, Lower Saxony.
The NAICS codes for geneXplain are [541, 541713, 54, 5417, 54171].
The SIC codes for geneXplain are [873, 87].